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Background: Fibromyalgia often coexists and overlaps with other
syndromes such as chronic fatigue, irritable bowel syndrome, and inter-
stitial cystitis. Chronic stress has been implicated in the pathogenesis of
these illnesses. The sympathetic nervous system is a key element of the
stress response system. Sympathetic dysfunction has been reported in
these syndromes, raising the possibility that such dysautonomia could be
their common clustering underlying pathogenesis.
Objective: The objective of this study was to carry out a review of all
published comparative case-control studies investigating sympathetic ner-
vous system performance in fibromyalgia, chronic fatigue syndrome,
irritable bowel syndrome, and interstitial cystitis.
Methods: Online databases PubMed and EMBASEwere accessed using
the following key words: autonomic (OR) sympathetic (AND) fibromy-
algia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial
cystitis. All entries up to December 10th 2012 were reviewed by 2 inde-
pendent investigators searching for case-control studies in humans. The
Method for Evaluating Research and Guidelines Evidence adapted to the
Scottish Intercollegiate Guidelines Network was used to rank the level of
evidence contained in the selected articles.
Results: A total of 196 articles are included in this review. Themost often
usedmethods to assess sympathetic functionality were heart rate variability
analysis, sympathetic skin response, tilt table testing, and genetic studies.
The majority of studies (65%) described sympathetic nervous system
predominance in these overlapping syndromes. In contrast, 7% of the
studies found parasympathetic predominance.
Conclusions: This review demonstrates that sympathetic nervous sys-
tem predominance is common in fibromyalgia, chronic fatigue syndrome,
irritable bowel syndrome, and interstitial cystitis. This concordance raises
the possibility that sympathetic dysfunction could be their common un-
derlying pathogenesis that brings on overlapping clinical features. The
recognition of sympathetic predominance in these 4 syndromes may
have potential clinical implications. It may be worth exploring the use of
nonpharmacological measures as well as drug therapies aimed to regain
autonomic balance.
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F ibromyalgia often coexists and overlaps with other contro-versial syndromes such as chronic fatigue, irritable bowel
syndrome, and interstitial cystitis.1 These syndromes are very
frequent in different clinical settings. The pathogenesis of these
illnesses has not been elucidated. Chronic stress has been im-
plicated in the development of fibromyalgia,2,3 chronic fatigue
syndrome,4 irritable bowel syndrome,5 and interstitial cystitis.6
An acceptable physiological definition of stress could be ‘‘any
stimuli, physical, or emotional that threatens homeostasis.’’2
The sympathetic nervous system is a key element of the
stress response system. Sympathetic dysfunction has been re-
ported in the 4 syndromes under discussion, raising the possi-
bility that such dysautonomia could be their common clustering
underlying pathogenesis.1
OBJECTIVE
The objective of this study was to carry out a review of all
published comparative case-control studies investigating sympa-
thetic nervous system performance in fibromyalgia, chronic fa-
tigue syndrome, irritable bowel syndrome, and interstitial cystitis.
METHODS
Online databases PubMed and EMBASE were accessed
using the following key words: autonomic (OR) sympa-
thetic, (AND) fibromyalgia, chronic fatigue syndrome, irri-
table bowel syndrome, and interstitial cystitis. All entries up
to December 10, 2012, were reviewed by 2 independent in-
vestigators searching for case-control studies in humans.
Included were articles written in English containing case-
control studies in patients with fibromyalgia, chronic fatigue syn-
drome, irritable bowel, or interstitial cystitis. Articles on patients
with presence of comorbid conditions other than the 4 syndromes
under discussion were excluded.
Two independent investigators reviewed, tabulated, and
ranked each article. If there were ranking discrepancies between
these 2 investigators, a third independent researcher moderated
the differences.
The Method for Evaluating Research and Guidelines Evi-
dence (MERGE)7 adapted to the Scottish Intercollegiate Guide-
lines Network (SIGN)8 was used to rank the level of evidence
contained in the selected articles. For each article, the following
items were evaluated: internal validity, selection of subjects, as-
sessment methods, and confounding factors. Each item was
ranked as ‘‘well covered,’’ ‘‘adequately addressed,’’ ‘‘poorly
addressed,’’ ‘‘not addressed,’’ ‘‘not reported,’’ or ‘‘not applica-
ble.’’ Reviewed articles were classified as ‘‘high quality’’ when
all or most of MERGE checklist items were fulfilled; ‘‘medium
quality,’’ when some checklist criteria were fulfilled, but those
items not fulfilled were thought unlikely to alter the conclu-
sions; and ‘‘low quality,’’ when few or none criteria were met.
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All reviewed case-control studies were included in the final
analysis.
‘‘Sympathetic predominance’’ was defined as statistically
significant data suggesting higher sympathetic activity, decreased
parasympathetic activity, or both. A reverse definition was applied
for ‘‘parasympathetic predominance.’’
Statistical Analysis
Descriptive statistic was used to summarize overall results.
A W2 method compared the proportion of studies describing
sympathetic predominance versus parasympathetic predomi-
nance for each of the 4 groups.
RESULTS
Our search identified 2257 abstracts listed in PubMed and/or
EMBASE databases. After review, 2061 were excluded for the
following reasons. They were not case-control studies, articles
were written in a language other than English, there was no
FIGURE. Literature search flowchart.
TABLE 1. SIGN 50 Checklist (n = 196 Articles)
SIGN 50 Assessment Points
Well
Covered, %
Adequately
Addressed, %
Poorly
Addressed, %
Not
Addressed, %
Not
Reported, %
Not
Applicable, %
The study addresses an appropriate
and clearly focused question
36.2 53.6 10.2 0 0 0
The patients and control subjects
are taken from comparable populations
40.8 40.8 13.3 4.1 0.5 0.5
The same exclusion criteria are used
for both patients and control subjects
50 25 18.9 4.6 1.5 0
Comparison is made between participants
and nonparticipants to establish their
similarities and differences
43.4 24.5 21.9 6.1 2 2
Patients are clearly defined and
differentiated from control subjects
34.2 44.4 17.9 3.6 0 0
It is clearly established that control
subjects are nonpatients
25 42.9 27 5.1 0 0
Measures will have been taken to
prevent knowledge of primary exposure
influencing case ascertainment
26 49.5 21.9 2 0 0.5
Exposure status is measured in a standard
valid and reliable way
27.6 52 16.3 3.1 1 0
The main potential confounders are
identified and taken into account in the
design and analysis
13.8 48 32.7 4.1 1 0.5
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control group, or the cases had comorbid conditions. The
remaining 196 articles are included in this review as shown in
the flowchart (Fig.). One hundred three cases were found in
both PubMed and EMBASE databases: Forty one articles were
found in PubMed, but not in EMBASE. In contrast EMBASE
contained 52 papers that were not listed in PubMed. Most of the
studies included both women and men (57%). Forty-two percent
of the studies were done only in female individuals. The remain-
ing 1% had only male participants. Most research protocols in-
cluded adult people. Thirteen chronic fatigue syndrome studies
were done in teenagers.
Table 1 depicts MERGE-SIGN 50 main checklist points.
Most articles had high and medium quality (Table 2). A wide
variety of methods were used to assess sympathetic nervous sys-
tem functionality. The most often used were heart rate variability
analysis, sympathetic skin response, tilt table testing, and genetic
studies, as listed in Table 3. A brief explanation of the most often
used methods follows: Heart rate variability analysis is a nonin-
vasive method to estimate autonomic nervous system perfor-
mance. This method is based on the fact that the heart rate is not
fixed; rather, it has a constant beat-to-beat temporal variation.
Computerized analysis of such variability yields a good estima-
tion of parasympathetic (or sympathetic) influx on the sinus node.
The autonomic nervous system is challenged during the tilt table
test. Symptoms, blood pressure, and heart rate are analyzed under
controlled conditions. The development of hypotension, tachy-
cardia, or syncope unveils a dysfunctional autonomic nervous
system. Sympathetic skin response is a method of measuring
the electrical conductance of the skin, which varies with its mois-
ture level. The sweat glands are controlled by the sympathetic
nervous system. Skin conductance is used as an indicator of
sympathetic activity. Several groups of investigators have studied
different genetic polymorphisms of key sympathetic elements.
They have focused on catechol-O-methyltransferase enzyme that
is in charge of clearing catecholamines from the system and the
adrenergic receptor that maintains cardiovascular homeostasis.
Additional methods were used to assess sympathetic nervous
system performance. In cases of interstitial cystitis, bladder bi-
opsies are done to estimate sympathetic innervation of the bladder
wall. There are validated questionnaires such as the COMPASS
questionnaire to evaluate the presence of dysautonomia symptoms.
The bottom of Table 3 includes 43 studies in the ‘‘other’’
category. This number reflects single techniques that were used to
test autonomic performance such as pupil response to stimuli,
ocular sympathetic innervation, photoplethysmography, blood
pressure and/or pulse response to diverse stimuli, and norepi-
nephrine injections, among many others. We recognize as a lim-
itation of our studies the fact that the wide variety of studies used
to test sympathetic nervous system performance diminishes the
consistency of the results.
The majority of studies (65%) described sympathetic ner-
vous system predominance in these painful syndromes (Table 4).
In contrast, 7% found parasympathetic predominance. Seventeen
percent of reviewed studies described autonomic dysfunction, but
the method used was not directed to define the predominant branch
of the autonomic system. Only 11% of studies found no differences
TABLE 2. Quality of Studies According to MERGE-SIGN 50 Checklist
Quality
Topic
Fibromyalgia Chronic Fatigue Irritable Bowel Interstitial Cystitis
n n n n
High quality (++) 24 27 12 3
Medium quality (+) 43 31 37 5
Low quality (j) 3 2 8 1
TABLE 3. Method Used to Assess Sympathetic Function
Method
Illness
Total
Fibromyalgia Chronic Fatigue Irritable Bowel Interstitial Cystitis
n n n n
Heart rate variability analysis 21 25 30 0 76
Tilt table 2 14 0 0 16
Hormones 6 2 2 0 10
Sympathetic skin response 12 2 3 1 18
Genetic studies 7 2 1 2 12
Symptom questionnaire 1 1 1 1 4
Electromyography 3 0 1 0 4
Sleep latency test 1 0 0 0 1
Electroencephalographic brain activity 0 0 3 0 3
Urinary bladder biopsy 0 0 0 3 3
Catecholamine levels 3 1 1 1 6
Others 14 13 15 1 43
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between patients and control subjects. For each of the 4 syndromes
under review, the difference between sympathetic predominance
versus parasympathetic predominance had P G 0.0001 according
to W2 test.P G 0.0001 did not change, when the 14 articles classified
as ‘‘low quality’’ were excluded from the analysis.
DISCUSSION
Sixty-five percent of the reviewed case-control articles of
fibromyalgia, chronic fatigue syndrome, irritable bowel syn-
drome, and interstitial cystitis described sympathetic nervous
system predominance. This association does not necessarily im-
ply a cause-effect relationship. The sympathetic dysfunction seen
in these syndromes could be secondary to nature or nurture un-
derpinnings. Different publications have associated fibromyalgia
with genetically defective catecholamine clearing enzymes.9 On
the other hand, the 4 syndromes under discussion are linked to
chronic stress3Y5 that can lead to sympathetic overactivity. The
possible role of the sympathetic nervous system in the pathogen-
esis of these syndromes has been better characterized in fibromy-
algia. Sympathetic hyperactivity may explain sleeping problems,
dry eyes, dry mouth, anxiety, and also widespread pain.2 A double-
blind study demonstrated that FM patients have norepinephrine-
evoked pain.10 Sympathetic hyperactivity may be one of several
predisposing elements to develop fibromyalgia. Trauma, infection,
or pain-related sodium-channel structure11 could be other contrib-
uting factors. It is clear that more research is needed to better
understand the pathogenesis of fibromyalgia and similar maladies.
We recognize limitations in our analysis. For a formal sys-
tematic review, the search strategy was not extensive enough. We
explored only PubMed and EMBASE databases. Other sources
such as CINAHL, PsycINFO, or ISI Web of Science could theo-
retically have additional relevant publications. Similarly, we did
not conduct forward and backward citation tracking, nor did we
search the ‘‘gray literature.’’ It seems unlikely, however, that these
additional sources would contain numerous case-control studies
that could significantly modify our results.
Another limiting factor of our review is the well-known
tendency to publish studies with positive results; therefore, our
findings of 11% of studies reporting no difference between pa-
tients and control subjects are possibly an underestimation. Fur-
thermore, the methods used to assess sympathetic performance
were heterogeneous, and some of them may have low specific-
ity value.
For the practicing clinician, it may be important to recog-
nize that sympathetic nervous system dysfunction is frequent in
patients who have fibromyalgia, chronic fatigue syndrome, ir-
ritable bowel syndrome, or/and interstitial cystitis. The sympa-
thetic nervous system is the main component of the stress
response system. Along these lines and from a philosophical
perspective, the presence of these syndromes could be viewed
as a failed attempt of our main complex adaptive system (the
autonomic nervous system) to adjust to a hostile environment.3
Therefore, nonpharmacological therapies aimed to modulate
sympathetic tone are recommended. Such therapies include re-
laxation techniques, breathing exercises, water-based exercises,
tai-chi, and cognitive-behavioral therapy. There is evidence that
these therapeutic modalities may alleviate patient symptoms.12
We are not aware of controlled studies testing the long-
term effect of pharmacological sympathetic blocking on these
syndromes. However, in a double-blind study done in patients
with fibromyalgia, acute adrenergic blockade with intravenous
propranolol led to decrease pain and hyperalgesia.13 Moreover,
a controlled study done in another stress-related syndrome,
temporomandibular joint dysfunction, showed that propranolol
may have a favorable effect on pain.14 It is surprising that de-
spite growing evidence of autonomic dysfunction in the 4 syn-
dromes under discussion, very few studies evaluate treatment
for sympathetic nervous system predominance.
CONCLUSIONS
This review suggests that sympathetic nervous system pre-
dominance is common in fibromyalgia, chronic fatigue syn-
drome, irritable bowel syndrome, and interstitial cystitis. This
concordance raises the possibility that sympathetic dysfunc-
tion could be their clustering underlying pathogenesis.
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